3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
50
Breast Neoplasms
25
Neoplasms
6
Neoplasm Metastasis
3
Prostate Adenocarcinoma
2
Breast Neoplasms, Male
2
Advanced Breast Cancer
2
Recurrence
1
Primary Ovarian Insufficiency
1
PSA Level Greater Than Two
1
Osteitis Deformans
1
Lymphatic Metastasis
1
Infertility
1
Hormone-sensitive Metastatic Breast Cancer
1
Hormone Sensitive Prostate Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
Advanced Metastatic Breast Cancer
1
Interventions
Sunitinib
3
avelumab
2
Nutrition Assessment
2
Axitinib
2
spartalizumab
1
pembrolizumab
1
etelcalcetide hydrochloride
1
aldesleukin
1
Sorafenib
1
Resistance Training
1
Plasma Exchange
1
Interleukin-2
1
Adalimumab
1
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Kidney Diseases
×
Goserelin
×
Clear all
No trials found.